Total Payments
$3,624
2024 Payments
$630.78
Companies
29
Transactions
191
Medicare Patients
18,335
Medicare Billing
$2.1M
Payment Breakdown by Category
Food & Beverage$3,624 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,624 | 191 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $569.17 | 27 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $479.27 | 24 | $0 (2024) |
| Novo Nordisk Inc | $376.98 | 22 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $272.98 | 15 | $0 (2022) |
| ABBVIE INC. | $271.00 | 13 | $0 (2024) |
| GlaxoSmithKline, LLC. | $216.01 | 11 | $0 (2024) |
| Lilly USA, LLC | $213.74 | 11 | $0 (2024) |
| Amgen Inc. | $154.88 | 8 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $144.42 | 8 | $0 (2024) |
| Amarin Pharma Inc. | $137.77 | 8 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $630.78 | 30 | ABBVIE INC. ($103.51) |
| 2023 | $598.36 | 30 | PFIZER INC. ($110.61) |
| 2022 | $563.84 | 30 | PFIZER INC. ($102.19) |
| 2021 | $652.52 | 34 | PFIZER INC. ($192.10) |
| 2020 | $638.07 | 34 | AstraZeneca Pharmaceuticals LP ($191.19) |
| 2019 | $196.30 | 12 | Amarin Pharma Inc. ($62.81) |
| 2018 | $288.69 | 17 | Allergan Inc. ($80.37) |
| 2017 | $55.58 | 4 | Boehringer Ingelheim Pharmaceuticals, Inc. ($23.99) |
All Payment Transactions
191 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/14/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: Oncology | ||||||
| 11/23/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/15/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $27.36 | General |
| Category: VACCINES | ||||||
| 11/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: NEUROSCIENCE | ||||||
| 11/02/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: Diabetes | ||||||
| 10/30/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $25.91 | General |
| Category: RESPIRATORY | ||||||
| 10/25/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: Inflammation | ||||||
| 10/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Diabetes | ||||||
| 08/31/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Diabetes | ||||||
| 08/23/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: Inflammation | ||||||
| 08/02/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: NEUROSCIENCE | ||||||
| 07/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.58 | General |
| Category: NEUROSCIENCE | ||||||
| 07/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: Diabetes | ||||||
| 06/28/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $29.23 | General |
| Category: Cardiovascular | ||||||
| 06/22/2024 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: Pharma Products | ||||||
| 06/07/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: Inflammation | ||||||
| 05/31/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: Diabetes | ||||||
| 05/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: RESPIRATORY | ||||||
| 05/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: Diabetes | ||||||
| 05/10/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: NEUROSCIENCE | ||||||
| 04/27/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Respiratory | ||||||
| 04/19/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $23.77 | General |
| 03/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: Diabetes | ||||||
| 03/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 4,843 | 7,266 | $1.0M | $539,240 |
| 2022 | 24 | 4,598 | 7,200 | $1.0M | $545,540 |
| 2021 | 23 | 4,603 | 7,574 | $1.0M | $550,861 |
| 2020 | 23 | 4,291 | 7,148 | $967,710 | $498,107 |
Total Patients
18,335
Total Services
29,188
Medicare Billing
$2.1M
Procedure Codes
98
All Medicare Procedures & Services
98 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 660 | 1,377 | $192,780 | $126,021 | 65.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 663 | 663 | $198,900 | $88,690 | 44.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 188 | 1,258 | $119,510 | $83,290 | 69.7% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 667 | 667 | $116,725 | $40,148 | 34.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 211 | 288 | $72,000 | $31,153 | 43.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 284 | 467 | $51,370 | $30,370 | 59.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 230 | 304 | $33,440 | $20,487 | 61.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 164 | 164 | $52,480 | $19,866 | 37.9% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 66 | 75 | $21,750 | $16,316 | 75.0% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 75 | 212 | $20,140 | $12,806 | 63.6% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 648 | 648 | $18,150 | $12,280 | 67.7% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 68 | 190 | $18,050 | $11,720 | 64.9% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Office | 2023 | 78 | 85 | $22,100 | $9,441 | 42.7% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 77 | 87 | $22,620 | $9,244 | 40.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 271 | 271 | $10,840 | $8,553 | 78.9% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 271 | 271 | $10,818 | $5,545 | 51.3% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 31 | 31 | $9,300 | $5,317 | 57.2% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 76 | 89 | $9,790 | $3,814 | 39.0% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 11 | 12 | $3,300 | $2,024 | 61.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $2,800 | $1,320 | 47.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 60 | 63 | $1,575 | $691.41 | 43.9% |
| G0403 | Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | Office | 2023 | 30 | 30 | $804.30 | $145.56 | 18.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 314 | 1,734 | $164,730 | $103,585 | 62.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 509 | 981 | $136,950 | $91,110 | 66.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 544 | 544 | $163,200 | $74,286 | 45.5% |
About Dr. Vanaja Sureddi, MD
Dr. Vanaja Sureddi, MD is a Internal Medicine healthcare provider based in Palm Beach Gardens, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/17/2008. The National Provider Identifier (NPI) number assigned to this provider is 1184895286.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vanaja Sureddi, MD has received a total of $3,624 in payments from pharmaceutical and medical device companies, with $630.78 received in 2024. These payments were reported across 191 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($3,624).
As a Medicare-enrolled provider, Sureddi has provided services to 18,335 Medicare beneficiaries, totaling 29,188 services with total Medicare billing of $2.1M. Data is available for 4 years (2020–2023), covering 98 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Palm Beach Gardens, FL
- Active Since 03/17/2008
- Last Updated 07/21/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1184895286
Products in Payments
- ELIQUIS (Drug) $364.68
- FARXIGA (Drug) $274.28
- XARELTO (Drug) $221.79
- MOUNJARO (Drug) $195.15
- TRELEGY ELLIPTA (Drug) $190.10
- Ozempic (Drug) $171.02
- VRAYLAR (Drug) $153.71
- XIFAXAN (Drug) $144.42
- Vascepa (Drug) $137.77
- CHANTIX (Drug) $136.91
- Rybelsus (Drug) $133.75
- UBRELVY (Drug) $101.75
- Otezla (Drug) $90.75
- ENTRESTO (Drug) $76.34
- BYSTOLIC (Drug) $75.52
- BREZTRI (Drug) $67.14
- JANUVIA (Drug) $63.72
- PREVNAR 20 (Biological) $53.35
- QUVIVIQ (Drug) $52.58
- INVOKANA (Drug) $51.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Palm Beach Gardens
Dr. Ravi Pandey, Md, MD
Internal Medicine — Payments: $17,395
Internal Medicine $17,395
Dr. Rupesh Dharia, M.d, M.D
Internal Medicine — Payments: $15,087
Internal Medicine $15,087
Amir Fahmy, Md, MD
Internal Medicine — Payments: $12,315
Internal Medicine $12,315
Romel Arjona, M.d, M.D
Internal Medicine — Payments: $9,757
Internal Medicine $9,757
Alissa O'brien, M.d, M.D
Internal Medicine — Payments: $7,028
Internal Medicine $7,028
Javier Canasi, Md, MD
Internal Medicine — Payments: $4,890
Internal Medicine $4,890